GGrantIndex
← Leaderboards

Michael N. Neely

University Of Florida

$9,304,264
Attributed
$10,563,798
Total exposure
8
Grants
7
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $2.2M · FY200725
$2.5M$1.9M$1.3M$625K$0
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$9,668,077 · 7
FDA$895,721 · 1

By mechanism

R01$8,446,341 · 4
U01$895,721 · 1
K23$466,224 · 1
P01$396,175 · 1
M01$359,337 · 1

Top collaborators

Most similar at University Of Florida

Same institution · by research overlap

Others in their field

Top investigators on “Pharmaceutical Preparations

Research focus

Pharmaceutical PreparationsDoseDrug KineticsInfectionComputer SoftwareBloodChildLaboratoriesPlasmaSamplingAlgorithmsResearch PersonnelInnovationLearningChildhoodRegimenBaseFutureVisitEnrollmentPharmacokinetic ModelAdolescentPharmacotherapyPharmacodynamics

Grant awards (28)

Optimizing Multi-drug Mycobacterium tuberculosis Therapy for Rapid Sterilization and Resistance Suppression$1,324,774
R01 · FY2025 · AI
Precision Dosing for Critically Ill Children$709,231
R01 · FY2025 · HD · contact PI
Core 3 Math Modeling Core$191,525
P01 · FY2025 · AI · contact PI
Precision Dosing for Critically Ill Children$706,469
R01 · FY2024 · HD · contact PI
Core 3 Math Modeling Core$204,650
P01 · FY2024 · AI · contact PI
Precision Dosing for Critically Ill Children$718,751
R01 · FY2023 · HD · contact PI
Precision Dosing for Critically Ill Children$725,833
R01 · FY2022 · HD · contact PI
PBPK and Population Modeling Seamlessly Linked to Clinical Trial Simulation in an Open-Source Software Platform$297,023
U01 · FY2020 · FD · contact PI
PBPK and Population Modeling Seamlessly Linked to Clinical Trial Simulation in an Open-Source Software Platform$299,474
U01 · FY2019 · FD · contact PI
PBPK and Population Modeling Seamlessly Linked to Clinical Trial Simulation in an Open-Source Software Platform$299,224
U01 · FY2018 · FD · contact PI
Ontogeny of Voriconazole Pharmaockinetics and Metabolism$482,498
R01 · FY2016 · HD · contact PI
Ontogeny of Voriconazole Pharmaockinetics and Metabolism$465,030
R01 · FY2015 · HD · contact PI
Population Pharmacokinetic Modeling and Dual Optimal Control$444,069
R01 · FY2015 · GM · contact PI
Ontogeny of Voriconazole Pharmaockinetics and Metabolism$486,666
R01 · FY2014 · HD · contact PI
Population Pharmacokinetic Modeling and Dual Optimal Control$442,455
R01 · FY2014 · GM · contact PI
Population Pharmacokinetic Modeling and Dual Optimal Control$431,780
R01 · FY2013 · GM · contact PI
Ontogeny of Voriconazole Pharmaockinetics and Metabolism$395,408
R01 · FY2013 · HD · contact PI
Ontogeny of Voriconazole Pharmaockinetics and Metabolism$101,731
R01 · FY2013 · HD · contact PI
Ontogeny of Voriconazole Pharmaockinetics and Metabolism$522,491
R01 · FY2012 · HD · contact PI
Population Pharmacokinetic Modeling and Dual Optimal Control$359,462
R01 · FY2012 · GM · contact PI
Population Pharmacokinetic Modeling and Dual Optimal Control$129,693
R01 · FY2012 · GM · contact PI
Plasma and Genital HIV Dynamics in Women$94,972
K23 · FY2010 · AI · contact PI
Plasma and Genital HIV Dynamics in Women$49,034
K23 · FY2010 · AI · contact PI
RALTEGRAVIR PHARMACOKINETICS WITH AND WITHOUT ATAZANAVIR IN HEALTHY ADULTS$359,337
M01 · FY2009 · RR · contact PI
Plasma and Genital HIV Dynamics in Women$92,763
K23 · FY2009 · AI · contact PI
Plasma and Genital HIV Dynamics in Women$50,000
K23 · FY2009 · AI · contact PI
Plasma and Genital HIV Dynamics in Women$90,568
K23 · FY2008 · AI · contact PI
Plasma and Genital HIV Dynamics in Women$88,887
K23 · FY2007 · AI · contact PI